{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:18:47Z","timestamp":1765354727567,"version":"3.37.3"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12328-020-01281-7","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T05:02:41Z","timestamp":1604466161000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies"],"prefix":"10.1007","volume":"14","author":[{"given":"Adnan","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rani","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9104-1702","authenticated-orcid":false,"given":"James H.","family":"Tabibian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"1281_CR1","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","volume":"110","author":"PA McCombe","year":"1987","unstructured":"McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain. 1987;110:1617\u201330.","journal-title":"Brain"},{"key":"1281_CR2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00415-003-1096-y","volume":"250","author":"M Odaka","year":"2003","unstructured":"Odaka M, Yuki N, Hirata K. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barre syndrome. J Neurol. 2003;250:913\u20136.","journal-title":"J Neurol"},{"key":"1281_CR3","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","volume":"74","author":"L Ruts","year":"2010","unstructured":"Ruts L, Drenthen J, Jacobs BC, et al. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010;74:1680\u20136.","journal-title":"Neurology"},{"key":"1281_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000494291","volume":"52","author":"MC Broers","year":"2019","unstructured":"Broers MC, Bunschoten C, Nieboer D, et al. Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology. 2019;52:161\u201372.","journal-title":"Neuroepidemiology"},{"key":"1281_CR5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","volume":"86","author":"EK Mathey","year":"2015","unstructured":"Mathey EK, Park SB, Hughes RA, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. 2015;86:973\u201385.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0032-1329194","volume":"32","author":"AC Peltier","year":"2012","unstructured":"Peltier AC, Donofrio PD. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside. Semin Neurol. 2012;32:187\u201395.","journal-title":"Semin Neurol"},{"key":"1281_CR7","first-page":"45","volume":"4","author":"M Mahdi-Rogers","year":"2010","unstructured":"Mahdi-Rogers M, Rajabally YA. Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins. Biologics. 2010;4:45\u20139.","journal-title":"Biologics"},{"key":"1281_CR8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/mus.26028","volume":"57","author":"YA Rajabally","year":"2018","unstructured":"Rajabally YA, Attarian S. Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review. Muscle Nerve. 2018;57:875\u201383.","journal-title":"Muscle Nerve"},{"key":"1281_CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaut.2019.04.021","volume":"102","author":"Y Rodriguez","year":"2019","unstructured":"Rodriguez Y, Vatti N, Ramirez-Santana C, et al. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease. J Autoimmun. 2019;102:8\u201337.","journal-title":"J Autoimmun"},{"key":"1281_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321250","author":"RAC Hughes","year":"2019","unstructured":"Hughes RAC. Defining chronic inflammatory demyelinating polyradiculoneuropathy subtypes. J Neurol Neurosurg Psychiatry. 2019. https:\/\/doi.org\/10.1136\/jnnp-2019-321250.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-320741","author":"S Ikeda","year":"2019","unstructured":"Ikeda S, Koike H, Nishi R, et al. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2019. https:\/\/doi.org\/10.1136\/jnnp-2019-320741.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jnnp-2012-302312","volume":"84","author":"T Kanda","year":"2013","unstructured":"Kanda T. Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies. J Neurol Neurosurg Psychiatry. 2013;84:208\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2165\/00003495-200969080-00004","volume":"69","author":"K Kuitwaard","year":"2009","unstructured":"Kuitwaard K, van Doorn PA. Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy. Drugs. 2009;69:987\u20131001.","journal-title":"Drugs"},{"key":"1281_CR14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fnins.2018.00597","volume":"12","author":"Q Liu","year":"2018","unstructured":"Liu Q, Wang X, Yi S. Pathophysiological Changes of Physical Barriers of Peripheral Nerves after Injury. Front Neurosci. 2018;12:597.","journal-title":"Front Neurosci"},{"key":"1281_CR15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","volume":"86","author":"K Doppler","year":"2015","unstructured":"Doppler K, Appeltshauser L, Wilhelmi K, et al. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies. J Neurol Neurosurg Psychiatry. 2015;86:720\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","volume":"88","author":"H Koike","year":"2017","unstructured":"Koike H, Kadoya M, Kaida KI, et al. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. J Neurol Neurosurg Psychiatry. 2017;88:465\u201373.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR17","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","volume":"79","author":"JK Ng","year":"2012","unstructured":"Ng JK, Malotka J, Kawakami N, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 2012;79:2241\u20138.","journal-title":"Neurology"},{"key":"1281_CR18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","volume":"73","author":"L Querol","year":"2013","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann Neurol. 2013;73:370\u201380.","journal-title":"Ann Neurol"},{"key":"1281_CR19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","volume":"27","author":"JM Vallat","year":"2017","unstructured":"Vallat JM, Yuki N, Sekiguchi K, et al. Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies. Neuromuscul Disord. 2017;27:290\u20133.","journal-title":"Neuromuscul Disord"},{"key":"1281_CR20","first-page":"621","volume":"50","author":"PJ Dyck","year":"1975","unstructured":"Dyck PJ, Lais AC, Ohta M, et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975;50:621\u201337.","journal-title":"Mayo Clin Proc"},{"key":"1281_CR21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11940-013-0229-6","volume":"15","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie MM, Barohn RJ. Chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol. 2013;15:350\u201366.","journal-title":"Curr Treat Options Neurol"},{"key":"1281_CR22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/B978-0-444-52902-2.00022-9","volume":"115","author":"G Said","year":"2013","unstructured":"Said G, Krarup C. Chronic inflammatory demyelinative polyneuropathy. Handb Clin Neurol. 2013;115:403\u201313.","journal-title":"Handb Clin Neurol"},{"key":"1281_CR23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/mus.25253","volume":"55","author":"Y Cao","year":"2017","unstructured":"Cao Y, Menon P, Ching-Fen Chang F, et al. Postural tremor and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2017;55:338\u201343.","journal-title":"Muscle Nerve"},{"key":"1281_CR24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s004150170093","volume":"248","author":"M Sabatelli","year":"2001","unstructured":"Sabatelli M, Madia F, Mignogna T, et al. Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol. 2001;248:772\u20137.","journal-title":"J Neurol"},{"key":"1281_CR25","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/jnnp-2012-303013","volume":"84","author":"TA Saifee","year":"2013","unstructured":"Saifee TA, Schwingenschuh P, Reilly MM, et al. Tremor in inflammatory neuropathies. J Neurol Neurosurg Psychiatry. 2013;84:1282\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.23821","volume":"48","author":"X Ayrignac","year":"2013","unstructured":"Ayrignac X, Viala K, Koutlidis RM, et al. Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity? Muscle Nerve. 2013;48:727\u201332.","journal-title":"Muscle Nerve"},{"key":"1281_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-510X(99)00317-2","volume":"173","author":"FT Rotta","year":"2000","unstructured":"Rotta FT, Sussman AT, Bradley WG, et al. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2000;173:129\u201339.","journal-title":"J Neurol Sci"},{"key":"1281_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1529-8027.2010.00251.x","volume":"15","author":"K Viala","year":"2010","unstructured":"Viala K, Maisonobe T, Stojkovic T, et al. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2010;15:50\u20136.","journal-title":"J Peripher Nerv Syst"},{"key":"1281_CR29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.55.8.677","volume":"55","author":"SJ Oh","year":"1992","unstructured":"Oh SJ, Joy JL, Kuruoglu R. \u201cChronic sensory demyelinating neuropathy\u201d: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry. 1992;55:677\u201380.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/CND.0b013e31822484fb","volume":"13","author":"YA Rajabally","year":"2012","unstructured":"Rajabally YA, Wong SL. Chronic inflammatory pure sensory polyradiculoneuropathy: a rare CIDP variant with unusual electrophysiology. J Clin Neuromuscul Dis. 2012;13:149\u201352.","journal-title":"J Clin Neuromuscul Dis"},{"key":"1281_CR31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-003-1068-2","volume":"250","author":"M Busby","year":"2003","unstructured":"Busby M, Donaghy M. Chronic dysimmune neuropathy A subclassification based upon the clinical features of 102 patients. J Neurol. 2003;250:714\u201324.","journal-title":"J Neurol"},{"key":"1281_CR32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000052136","volume":"45","author":"N Ohkoshi","year":"2001","unstructured":"Ohkoshi N, Harada K, Nagata H, et al. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves. Eur Neurol. 2001;45:241\u20138.","journal-title":"Eur Neurol"},{"key":"1281_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(00)00493-7","volume":"184","author":"N Hattori","year":"2001","unstructured":"Hattori N, Misu K, Koike H, et al. Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2001;184:57\u201363.","journal-title":"J Neurol Sci"},{"key":"1281_CR34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-009-5386-x","volume":"257","author":"A Kimura","year":"2010","unstructured":"Kimura A, Sakurai T, Koumura A, et al. Motor-dominant chronic inflammatory demyelinating polyneuropathy. J Neurol. 2010;257:621\u20139.","journal-title":"J Neurol"},{"key":"1281_CR35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jns5.12053","volume":"19","author":"E Nobile-Orazio","year":"2014","unstructured":"Nobile-Orazio E. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. J Peripher Nerv Syst. 2014;19:2\u201313.","journal-title":"J Peripher Nerv Syst"},{"key":"1281_CR36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","volume":"54","author":"JS Katz","year":"2000","unstructured":"Katz JS, Saperstein DS, Gronseth G, et al. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000;54:615\u201320.","journal-title":"Neurology"},{"key":"1281_CR37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","volume":"24","author":"DS Saperstein","year":"2001","unstructured":"Saperstein DS, Katz JS, Amato AA, et al. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. 2001;24:311\u201324.","journal-title":"Muscle Nerve"},{"key":"1281_CR38","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","volume":"32","author":"RA Lewis","year":"1982","unstructured":"Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982;32:958\u201364.","journal-title":"Neurology"},{"key":"1281_CR39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/119.3.765","volume":"119","author":"PK Thomas","year":"1996","unstructured":"Thomas PK, Claus D, Jaspert A, et al. Focal upper limb demyelinating neuropathy. Brain. 1996;119:765\u201374.","journal-title":"Brain"},{"key":"1281_CR40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mus.23541","volume":"47","author":"X Ayrignac","year":"2013","unstructured":"Ayrignac X, Rodrigues Bienvenu S, Morales R, et al. Focal CIDP presenting as chronic progressive monomelic sensory neuropathy. Muscle Nerve. 2013;47:143\u20134.","journal-title":"Muscle Nerve"},{"key":"1281_CR41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","volume":"57","author":"M Donaghy","year":"1994","unstructured":"Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry. 1994;57:778\u201383.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","volume":"8","author":"JJ Devaux","year":"2016","unstructured":"Devaux JJ, Miura Y, Fukami Y, et al. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology. 2016;8:800\u20137.","journal-title":"Neurology"},{"key":"1281_CR43","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/jnnp-2018-318170","volume":"89","author":"K Doppler","year":"2018","unstructured":"Doppler K, Stengel H, Appeltshauser L, et al. Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies. J Neurol Neurosurg Psychiatry. 2018;89:1145\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","volume":"301","author":"M Kadoya","year":"2016","unstructured":"Kadoya M, Kaida K, Koike H, et al. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay. J Neuroimmunol. 2016;301:16\u201322.","journal-title":"J Neuroimmunol"},{"key":"1281_CR45","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","volume":"2","author":"H Ogata","year":"2015","unstructured":"Ogata H, Yamasaki R, Hiwatashi A, et al. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol. 2015;2:960\u201371.","journal-title":"Ann Clin Transl Neurol"},{"key":"1281_CR46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","volume":"82","author":"L Querol","year":"2014","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 2014;82:879\u201386.","journal-title":"Neurology"},{"key":"1281_CR47","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","volume":"138","author":"Y Miura","year":"2015","unstructured":"Miura Y, Devaux JJ, Fukami Y, et al. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain. 2015;138:1484\u201391.","journal-title":"Brain"},{"key":"1281_CR48","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1474-4422(19)30144-9","volume":"18","author":"C Bunschoten","year":"2019","unstructured":"Bunschoten C, Jacobs BC, Van den Bergh PYK, et al. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019;18:784\u201394.","journal-title":"Lancet Neurol"},{"key":"1281_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.11.015","volume":"277","author":"CL Koski","year":"2009","unstructured":"Koski CL, Baumgarten M, Magder LS, et al. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2009;277:1\u20138.","journal-title":"J Neurol Sci"},{"key":"1281_CR50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Van den Bergh","year":"2010","unstructured":"Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol. 2010;17:356\u201363.","journal-title":"Eur J Neurol"},{"key":"1281_CR51","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/jnnp.2009.179358","volume":"80","author":"YA Rajabally","year":"2009","unstructured":"Rajabally YA, Nicolas G, Pieret F, et al. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry. 2009;80:1364\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-1331.2006.01278.x","volume":"13","author":"RA Hughes","year":"2006","unstructured":"Hughes RA, Bouche P, Cornblath DR, et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2006;13:326\u201332.","journal-title":"Eur J Neurol"},{"key":"1281_CR53","unstructured":"Dyck P, Pollard J. Chronic inflammatory demyelinating polyneuropathy. Dyck P, Thomas P, Griffin J, et al. (eds), Peripheral Neuropathy. Philadelphia, Saunders 1993."},{"key":"1281_CR54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","volume":"29","author":"PY Van den Bergh","year":"2004","unstructured":"Van den Bergh PY, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2004;29:565\u201374.","journal-title":"Muscle Nerve"},{"key":"1281_CR55","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","volume":"46","author":"RJ Barohn","year":"1989","unstructured":"Barohn RJ, Kissel JT, Warmolts JR, et al. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol. 1989;46:878\u201384.","journal-title":"Arch Neurol"},{"key":"1281_CR56","doi-asserted-by":"crossref","unstructured":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 617\u20138.","DOI":"10.1212\/WNL.41.5.617"},{"key":"1281_CR57","doi-asserted-by":"crossref","unstructured":"Joint Task Force of the E, the PNS. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2013First Revision. J Peripher Nerv Syst 2010; 15: 1\u20139.","DOI":"10.1111\/j.1529-8027.2010.00245.x"},{"key":"1281_CR58","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/brain\/124.12.2427","volume":"124","author":"WM Bosboom","year":"2001","unstructured":"Bosboom WM, van den Berg LH, Franssen H, et al. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain. 2001;124:2427\u201338.","journal-title":"Brain"},{"key":"1281_CR59","doi-asserted-by":"crossref","unstructured":"England JD, Gronseth GS, Franklin G, et al. Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM R 2009; 1: 14\u201322.","DOI":"10.1016\/j.pmrj.2008.11.011"},{"key":"1281_CR60","doi-asserted-by":"crossref","unstructured":"Mehndiratta MM, Hughes RA. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2002: CD002062.","DOI":"10.1002\/14651858.CD002062"},{"key":"1281_CR61","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1756285612457215","volume":"5","author":"KC Gorson","year":"2012","unstructured":"Gorson KC. An update on the management of chronic inflammatory demyelinating polyneuropathy. Ther Adv Neurol Disord. 2012;5:359\u201373.","journal-title":"Ther Adv Neurol Disord"},{"issue":"Suppl","key":"1281_CR62","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ana.410090719","volume":"9","author":"MC Dalakas","year":"1981","unstructured":"Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol. 1981;9(Suppl):134\u201345.","journal-title":"Ann Neurol"},{"key":"1281_CR63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2013.01.001","volume":"256","author":"S Bick","year":"2013","unstructured":"Bick S, Tschernatsch M, Karg A, et al. Intravenous immunoglobulin inhibits BAFF production in chronic inflammatory demyelinating polyneuropathy - a new mechanism of action? J Neuroimmunol. 2013;256:84\u201390.","journal-title":"J Neuroimmunol"},{"key":"1281_CR64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","volume":"314","author":"PJ Dyck","year":"1986","unstructured":"Dyck PJ, Daube J, O\u2019Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med. 1986;314:461\u20135.","journal-title":"N Engl J Med"},{"key":"1281_CR65","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Pillay N, et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain. 1996;119:1055\u201366.","journal-title":"Brain"},{"key":"1281_CR66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","volume":"7","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC. Medscape. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol. 2011;7:507\u201317.","journal-title":"Nat Rev Neurol"},{"key":"1281_CR67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000331011","volume":"66","author":"N Galldiks","year":"2011","unstructured":"Galldiks N, Burghaus L, Dohmen C, et al. Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment. Eur Neurol. 2011;66:183\u20139.","journal-title":"Eur Neurol"},{"key":"1281_CR68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1529-8027.2009.00221.x","volume":"14","author":"M Mahdi-Rogers","year":"2009","unstructured":"Mahdi-Rogers M, Kazmi M, Ferner R, et al. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy. J Peripher Nerv Syst. 2009;14:118\u201324.","journal-title":"J Peripher Nerv Syst"},{"key":"1281_CR69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.2005.065441","volume":"77","author":"S Kuwabara","year":"2006","unstructured":"Kuwabara S, Misawa S, Mori M, et al. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. J Neurol Neurosurg Psychiatry. 2006;77:66\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"1281_CR70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1529-8027.2011.00298.x","volume":"16","author":"TH Brannagan 3rd","year":"2011","unstructured":"Brannagan TH 3rd. Current diagnosis of CIDP: the need for biomarkers. J Peripher Nerv Syst. 2011;16(Suppl 1):3\u201313.","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl 1","key":"1281_CR71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1529-8027.2011.00299.x","volume":"16","author":"N Latov","year":"2011","unstructured":"Latov N. Biomarkers of CIDP in patients with diabetes or CMT1. J Peripher Nerv Syst. 2011;16(Suppl 1):14\u20137.","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl 1","key":"1281_CR72","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1529-8027.2011.00310.x","volume":"16","author":"HJ Willison","year":"2011","unstructured":"Willison HJ. Biomarkers in experimental models of antibody-mediated neuropathies. J Peripher Nerv Syst. 2011;16(Suppl 1):60\u20132.","journal-title":"J Peripher Nerv Syst"},{"key":"1281_CR73","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1017\/S0317167100041974","volume":"19","author":"CH Chalk","year":"1992","unstructured":"Chalk CH, Windebank AJ, Kimmel DW, et al. The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neurol Sci. 1992;19:346\u201351.","journal-title":"Can J Neurol Sci"},{"key":"1281_CR74","first-page":"1","volume":"7","author":"J Chawla","year":"2006","unstructured":"Chawla J, Fisher A. Gastric carcinoma presenting with chronic inflammatory demyelinating polyneuropathy. Internet J Neurol. 2006;7:1\u20135.","journal-title":"Internet J Neurol"},{"key":"1281_CR75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000338296","volume":"4","author":"S Mostoufizadeh","year":"2012","unstructured":"Mostoufizadeh S, Souri M, de Seze J. A case of paraneoplastic demyelinating motor polyneuropathy. Case Rep Neurol. 2012;4:71\u20136.","journal-title":"Case Rep Neurol"},{"key":"1281_CR76","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1212\/WNL.51.6.1738","volume":"51","author":"MD Weiss","year":"1998","unstructured":"Weiss MD, Luciano CA, Semino-Mora C, et al. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology. 1998;51:1738\u201341.","journal-title":"Neurology"},{"key":"1281_CR77","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1468-1331.2007.01990.x","volume":"14","author":"E Lagrange","year":"2007","unstructured":"Lagrange E, Veran O, Besson G. Pure motor relapsing Guillain Barr\u00e9 syndrome associated with anti-GM1 antibodies revealing urinary bladder cancer. Eur J Neurol. 2007;14:e7.","journal-title":"Eur J Neurol"},{"key":"1281_CR78","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mus.24510","volume":"51","author":"S Ayyappan","year":"2015","unstructured":"Ayyappan S, Day T, Kiers L. Distal acquired demyelinating symmetric (DADS) neuropathy associated with colorectal adenocarcinoma. Muscle Nerve. 2015;51:928\u201331.","journal-title":"Muscle Nerve"},{"key":"1281_CR79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/brain\/90.1.31","volume":"90","author":"PB Croft","year":"1967","unstructured":"Croft PB, Urich H, Wilkinson M. Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain. 1967;90:31\u201366.","journal-title":"Brain"},{"key":"1281_CR80","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/mus.24951","volume":"53","author":"G Galassi","year":"2016","unstructured":"Galassi G, Luppi G. Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: Should it be termed paraneoplastic? Muscle Nerve. 2016;53:658\u20139.","journal-title":"Muscle Nerve"},{"key":"1281_CR81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp.60.2.188","volume":"60","author":"JC Antoine","year":"1996","unstructured":"Antoine JC, Mosnier JF, Lapras J, et al. Chronic inflammatory demyelinating polyneuropathy associated with carcinoma. J Neurol Neurosurg Psychiatry. 1996;60:188\u201390.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR82","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jnnp.65.3.403a","volume":"65","author":"K Abe","year":"1998","unstructured":"Abe K, Sugai F. Chronic inflammatory demyelinating polyneuropathy accompanied by carcinoma. J Neurol Neurosurg Psychiatry. 1998;65:403\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1281_CR83","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1023\/A:1005690908999","volume":"45","author":"MR Arguedas","year":"2000","unstructured":"Arguedas MR, McGuire BM. Hepatocellular carcinoma presenting with chronic inflammatory demyelinating polyradiculoneuropathy. Dig Dis Sci. 2000;45:2369\u201373.","journal-title":"Dig Dis Sci"},{"key":"1281_CR84","first-page":"3418950","volume":"2019","author":"RML Colunga Biancatelli","year":"2019","unstructured":"Colunga Biancatelli RML, Ciacciarelli M, Polidoro A, et al. Combined hepatocholangiocarcinoma associated with humoral hypercalcemia of malignancy and chronic inflammatory demyelinating polyneuropathy. Case Rep Oncol Med. 2019;2019:3418950.","journal-title":"Case Rep Oncol Med"},{"key":"1281_CR85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2169\/internalmedicine.36.53","volume":"36","author":"F Sugai","year":"1997","unstructured":"Sugai F, Abe K, Fujimoto T, et al. Chronic inflammatory demyelinating polyneuropathy accompanied by hepatocellular carcinoma. Intern Med. 1997;36:53\u20135.","journal-title":"Intern Med"},{"key":"1281_CR86","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1468-1331.2010.03095.x","volume":"18","author":"L Benavente","year":"2011","unstructured":"Benavente L, Moris G. Neurologic disorders associated with inflammatory bowel disease. Eur J Neurol. 2011;18:138\u201343.","journal-title":"Eur J Neurol"},{"key":"1281_CR87","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11910-014-0487-z","volume":"14","author":"JM Ferro","year":"2014","unstructured":"Ferro JM, Oliveira S. Neurologic manifestations of gastrointestinal and liver diseases. Curr Neurol Neurosci Rep. 2014;14:487.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1281_CR88","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1212\/WNL.45.3.416","volume":"45","author":"A Lossos","year":"1995","unstructured":"Lossos A, River Y, Eliakim A, et al. Neurologic aspects of inflammatory bowel disease. Neurology. 1995;45:416\u201321.","journal-title":"Neurology"},{"key":"1281_CR89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12883-015-0302-8","volume":"15","author":"S Kim","year":"2015","unstructured":"Kim S, Kang SJ, Oh KW, et al. Chronic inflammatory demyelinating polyneuropathy-like neuropathy as an initial presentation of Crohn\u2019s disease. BMC Neurol. 2015;15:48.","journal-title":"BMC Neurol"},{"key":"1281_CR90","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","volume":"352","author":"H Koller","year":"2005","unstructured":"Koller H, Kieseier BC, Jander S, et al. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med. 2005;352:1343\u201356.","journal-title":"N Engl J Med"},{"key":"1281_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14044","author":"PE Doneddu","year":"2019","unstructured":"Doneddu PE, Bianchi E, Cocito D, et al. Risk factors for CIDP: antecedent events, lifestyle and dietary habits. Data from the Italian CIDP database. Eur J Neurol. 2019. https:\/\/doi.org\/10.1111\/ene.14044.","journal-title":"Eur J Neurol"},{"key":"1281_CR92","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s004150050531","volume":"246","author":"GW van Dijk","year":"1999","unstructured":"van Dijk GW, Notermans NC, Franssen H, et al. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study. J Neurol. 1999;246:1134\u20139.","journal-title":"J Neurol"},{"key":"1281_CR93","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/brain\/awh429","volume":"128","author":"FA Gondim","year":"2005","unstructured":"Gondim FA, Brannagan TH, Sander HW, et al. Peripheral neuropathy in patients with inflammatory bowel disease. Brain. 2005;128:867\u201379.","journal-title":"Brain"},{"key":"1281_CR94","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2015.11.048","volume":"360","author":"P Lozeron","year":"2016","unstructured":"Lozeron P, Lacour MC, Vandendries C, et al. Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies. J Neurol Sci. 2016;360:170\u20135.","journal-title":"J Neurol Sci"},{"key":"1281_CR95","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mus.25368","volume":"55","author":"T Ishikawa","year":"2017","unstructured":"Ishikawa T, Asakura K, Mizutani Y, et al. MR neurography for the evaluation of CIDP. Muscle Nerve. 2017;55:483\u20139.","journal-title":"Muscle Nerve"},{"key":"1281_CR96","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410390417","volume":"39","author":"M Carpo","year":"1996","unstructured":"Carpo M, Nobile-Orazio E, Meucci N, et al. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann Neurol. 1996;39:539\u201343.","journal-title":"Ann Neurol"},{"key":"1281_CR97","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/WCO.0000000000000475","volume":"30","author":"JC Antoine","year":"2017","unstructured":"Antoine JC, Camdessanche JP, et al. Paraneoplastic neuropathies. Curr Opin Neurol. 2017;30:513\u201320.","journal-title":"Curr Opin Neurol"},{"key":"1281_CR98","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.wco.0000173462.17135.ee","volume":"18","author":"S Rudnicki","year":"2005","unstructured":"Rudnicki S, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005;18:598\u2013603.","journal-title":"Curr Opin Neurol"},{"key":"1281_CR99","first-page":"325","volume":"61","author":"C Rozsa","year":"2008","unstructured":"Rozsa C, Vincent A, Aranyi Z, et al. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer. Ideggyogy Sz. 2008;61:325\u20138.","journal-title":"Ideggyogy Sz"},{"key":"1281_CR100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","volume":"49","author":"JC Antoine","year":"2001","unstructured":"Antoine JC, Honnorat J, Camdessanch\u00e9 JP, et al. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol. 2001;49:214\u201321.","journal-title":"Ann Neurol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01281-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-020-01281-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01281-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:30:43Z","timestamp":1613694643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-020-01281-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1007\/s12328-020-01281-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Adnan Malik, Rani Berry, Brian M Fung and James H Tabibian declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"NA- clinical review manuscript (i.e. not an original study).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"NA\u2014no human subjects in this clinical review manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}